Omkar Pharmachem Stock Screener | Share Price & Fundamental Analysis
OMKARPH
Commodity Chemicals
Screen Omkar Pharmachem share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹29.74
▲
2.97 (11.09%)
Market Cap
₹28.60 Cr.
P/E Ratio (TTM)
157.39
P/B Ratio
3.03
EPS (TTM)
₹0.20
Dividend Yield
-
Debt to Equity
0.02
52W High
₹30.00
52W Low
₹25.50
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹10.00
Total Equity
₹9.00
Omkar Pharmachem Share Price History - Stock Screener Chart
Screen OMKARPH historical share price movements with interactive charts. Analyze price trends and patterns.
Omkar Pharmachem Company Profile - Fundamental Screener
Screen Omkar Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for OMKARPH shares.
Sector
Chemicals
Industry
Commodity Chemicals
Sub-Sector
Commodity Chemicals
Segment
E
ISIN
INE501C01015
Omkar Pharmachem Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen OMKARPH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 10 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 10 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 9 | 9 | 9 | 9 | 9 | 8 | 9 | 9 | 9 | 9 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -1 | -1 | -1 |
Screen OMKARPH income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 0.00% | 54.00% | 52.00% | 58.00% | 50.00% | 8.00% | -454.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.20 | 0.20 | 0.19 | 0.20 | 0.18 | 0.22 | -0.26 | -0.42 | -0.25 | 0.22 | -0.12 | -0.06 |
Omkar Pharmachem Cash Flow Screener - Liquidity Fundamentals
Screen OMKARPH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen OMKARPH shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% |
| Other Holding | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% |
| Shareholder Count | 3,611 | 3,619 | 3,618 | 3,601 | 3,609 | 3,608 | 3,609 | 3,573 |
Omkar Pharmachem Dividend Screener - Share Yield Analysis
Screen OMKARPH dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Omkar Pharmachem Index Membership - Market Screener Classification
Screen OMKARPH by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Omkar Pharmachem Market Events Screener - Corporate Actions
Screen OMKARPH market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.00% | ||
| Annual General Meeting | NA | 4.48% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -6.67% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 4.97% |
Omkar Pharmachem Competitors Screener - Peer Comparison
Screen OMKARPH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Tata Chemicals | 21,531 | 54.66 | 15,112 | -3.79% | 354 | 33.39 |
| Deepak Fertilisers & Petrochemicals | 17,675 | 18.22 | 10,355 | 17.69% | 945 | 41.75 |
| Gujarat Narmada Valley Fert & Chem | 7,226 | 12.81 | 8,393 | -0.07% | 586 | 39.89 |
| GHCL | 5,956 | 10.43 | 3,271 | -6.51% | 624 | 47.86 |
| Fischer Medical Ventures | 5,947 | 299.03 | 112 | 421.86% | 1 | 39.95 |
| Chemplast Sanmar | 5,828 | -30.00 | 4,393 | 9.61% | -110 | 40.78 |
| Blue Pearl Agriventures | 5,232 | 9139.00 | 35 | 11666.67% | 1 | 60.55 |
| Gujarat Alkalies & Chemicals | 4,070 | -119.86 | 4,165 | 6.89% | -65 | 45.83 |
| Tanfac Industries | 3,915 | 42.76 | 560 | 45.35% | 88 | 47.37 |
| Grauer & Weil | 3,659 | 24.23 | 1,180 | 7.28% | 157 | 37.19 |
Omkar Pharmachem Company Announcements - News Screener
Screen OMKARPH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Board Meeting Intimation for Board Meeting Intimation For Inter-Alia To Consider Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter And Half Yearly Ended September 30 2025 | View |
| 2025-10-28 | Report On Action Taken Under The Special Window For Re-Lodgement Of Transfer Requests For The Month Of September 2025 | View |
| 2025-10-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-27 | Closure of Trading Window | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-29 | Corporate Action-Fixes Record Date For 30Th AGM | View |
| 2025-08-29 | Reg. 34 (1) Annual Report. | View |
| 2025-08-29 | 30Th AGM Scheduled To Be Held On 24Th Day Of September 2025 | View |
| 2025-08-27 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-08-27 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 27Th August 2025 | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-13 | Results- Financial Results For June 2025 | View |
| 2025-08-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August 2025 | View |
| 2025-08-05 | Board Meeting Intimation for Inter-Alia To Consider Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30 2025. | View |
| 2025-07-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-06-28 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-06-26 | Closure of Trading Window | View |